Schedule 13D ownership disclosure
XTANT MED HLDGS INC
Common Stock, par value $0.000001 per share · CUSIP: 98420P308
Event date: 2025-04-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Partners Limited PartnershipReported CIK 0001502725
Shares: 16,380,396.00 · Class: 11.8%
- Nantahala Capital Management, LLCReported CIK 0001472322
Shares: 68,394,000.00 · Class: 49.1%
- Wilmot B. HarkeyReported CIK 0001775952
Shares: 68,394,000.00 · Class: 49.1%
- Daniel MackReported CIK 0001775831
Shares: 68,394,000.00 · Class: 49.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-036047
- Form type
- SCHEDULE 13D
- Filer
- Nantahala Capital Management, LLC
- CIK
- CIK 1472322
- Filed
- Apr 17, 2025
- Reporting period
- Apr 10, 2025
- Description
- Schedule 13D beneficial ownership